The false positive rate of using a more internal position of SP100 or TGFB3 to detect intermediate/high Gleason score cancers is also low, at 8.7% and 0%, respectively, since SP100 was more internally repositioned in only two of the 23 benign tissues and low Gleason score cancer specimens and TGFB3 was not more internally repositioned in these groups of tissues (N = 23; Table 1 and 5). The gene discussed is TGFB3; the disease is cancer.